Oppenheimer & CO Inc Red Hill Biopharma Ltd. Transaction History

Oppenheimer & CO Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 01, 2018	SELL	$4.96 - $6.84 $63,488 - $87,552	-12,800 Closed	0 $0
Q4 2017 Feb 07, 2018	SELL	$4.58 - $10.81 $8,789 - $20,744	-1,919 Reduced 13.04%	12,800 $66,000
Q3 2017 Nov 09, 2017	BUY	$8.25 - $10.81 $121,431 - $159,112	14,719	14,719 $159,000

40.4K

Ticker RDHL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 63,823,500
Market Cap $465M
Description
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Oppenheimer & CO Inc with notifications on news.